Current Psychopharmacology of Obsessive-Compulsive Spectrum Disorders

Author(s): Antonio Del Casale, Georgios D. Kotzalidis, Chiara Rapinesi, Paolo Girardi*.

Journal Name: Current Neuropharmacology

Volume 17 , Issue 8 , 2019

Become EABM
Become Reviewer

[1]
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5); Arlington, VA: American Psychiatric Association, 2013.
[2]
Rasmussen, S.A.; Eisen, J.L. The epidemiology and differential diagnosis of obsessive compulsive disorder. J. Clin. Psychiatry, 1994, 55(4)(Suppl.), 5-10. discussion 11-14
[3]
Ruscio, A.M.; Stein, D.J.; Chiu, W.T.; Kessler, R.C. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol. Psychiatry, 2010, 15(1), 53-63.
[4]
Kessler, R.C.; Berglund, P.; Demler, O.; Jin, R.; Merikangas, K.R.; Walters, E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry, 2005, 62, 593-602.
[5]
Heyman, I.; Fombonne, E.; Simmons, H.; Ford, T.; Meltzer, H.; Goodman, R. Prevalence of obsessive-compulsive disorder in the British nationwide survey of child mental health. Int. Rev. Psychiatry, 2003, 15, 178-184.
[6]
Anholt, G.E.; Aderka, I.M.; van Balkom, A.J.; Smit, J.H.
Schruers, K.; van der Wee, N.J.; Eikelenboom, M.; De Luca, V.; van Oppen, P. Age of onset in obsessive-compulsive disorder: admixture analysis with a large sample. Psychol. Med., 2014, 44(1), 185-194.
[7]
Mataix-Cols, D.; Marks, I.M.; Greist, J.H.; Kobak, K.A.; Baer, L. Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: Results from a controlled trial. Psychother. Psychosom., 2002, 71(5), 255-262.
[8]
Stewart, S.E.; Geller, D.A.; Jenike, M.; Pauls, D.; Shaw, D.; Mullin, B.; Faraone, S.V. Long-term outcome of pediatric obsessive-compulsive disorder: A meta-analysis and qualitative review of the literature. Acta Psychiatr. Scand., 2004, 110, 4-13.
[9]
Hirschtritt, M.E.; Bloch, M.H.; Mathews, C.A. Obsessive-compulsive disorder: advances in diagnosis and treatment. JAMA, 2017, 317(13), 1358-1367.
[10]
Torres, A.R.; Prince, M.J.; Bebbington, P.E.; Bhugra, D.K.; Brugha, T.S.; Farrell, M.; Jenkins, R.; Lewis, G.; Meltzer, H.; Singleton, N. Treatment seeking by individuals with obsessive-compulsive disorder from the British Psychiatric Morbidity Survey of 2000. Psychiatr. Serv., 2007, 58(7), 977-982.
[11]
Torres, A.R.; Prince, M.J.; Bebbington, P.E.; Bhugra, D.; Brugha, T.S.; Farrell, M.; Jenkins, R.; Lewis, G.; Meltzer, H.; Singleton, N. Obsessive compulsive disorder: prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000. Am. J. Psychiatry, 2006, 163, 1978-1985.
[12]
Dell’Osso, B.; Benatti, B.; Hollander, E.; Fineberg, N.; Stein, D.J.; Lochner, C.; Nicolini, H.; Lanzagorta, N.; Palazzo, C.; Altamura, A.C.; Marazziti, D.; Pallanti, S.; Van Ameringen, M.; Karamustafalioglu, O.; Drummond, L.M.; Hranov, L.; Figee, M.; Grant, J.E.; Zohar, J.; Denys, D.; Menchon, J.M. Childhood, adolescent and adult age at onset and related clinical correlates in obsessive-compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS). Int. J. Psychiatry Clin. Pract., 2016, 20(4), 210-217.
[13]
Taylor, S. Early versus late onset obsessive-compulsive disorder: evidence for distinct subtypes. Clin. Psychol. Rev., 2011, 31(7), 1083-1100.
[14]
Alvarenga, P.G.; Cesar, R.C.; Leckman, J.F.; Moriyama, T.S.; Torres, A.R.; Bloch, M.H.; Coughlin, C.G.; Hoexter, M.Q.; Manfro, G.G.; Polanczyk, G.V.; Miguel, E.C.; do Rosario, M.C. Obsessive-compulsive symptom dimensions in a population-based, cross-sectional sample of school-aged children. J. Psychiatr. Res., 2015, 62, 108-114.
[15]
Fullana, M.A.; Mataix-Cols, D.; Caspi, A.; Harrington, H.; Grisham, J.R.; Moffitt, T.E.; Poulton, R. Obsessions and compulsions in the community: Prevalence, interference, help-seeking, developmental stability, and co-occurring psychiatric conditions. Am. J. Psychiatry, 2009, 166(3), 329-336.
[16]
Alvarenga, P.G.; do Rosario, M.C.; Cesar, R.C.; Manfro, G.G.; Moriyama, T.S.; Bloch, M.H.; Shavitt, R.G.; Hoexter, M.Q.; Coughlin, C.G.; Leckman, J.F.; Miguel, E.C. Obsessive-compulsive symptoms are associated with psychiatric comorbidities, behavioral and clinical problems: A population-based study of Brazilian school children. Eur. Child Adolesc. Psychiatry, 2016, 25(2), 175-182.
[17]
Dell’Osso, B.; Camuri, G.; Benatti, B.; Buoli, M.; Altamura, A.C. Differences in latency to first pharmacological treatment (duration of untreated illness) in anxiety disorders: A study on patients with panic disorder, generalized anxiety disorder and obsessive-compulsive disorder. Early Interv. Psychiatry, 2013, 7(4), 374-380.
[18]
Mancebo, M.C.; Boisseau, C.L.; Garnaat, S.L.; Eisen, J.L.; Greenberg, B.D.; Sibrava, N.J.; Stout, R.L.; Rasmussen, S.A. Long-term course of pediatric obsessive-compulsive disorder: 3 years of prospective follow-up. Compr. Psychiatry, 2014, 55(7), 1498-1504.
[19]
Eddy, C.M.; Cavanna, A.E. Tourette syndrome and obsessive compulsive disorder: Compulsivity along the continuum. J. Obsessive Compuls. Relat. Disord., 2014, 3, 363-371.
[20]
Hartmann, A.; Millet, B. Repetitive movements and behaviors in neurological and psychiatric practice: Distinctions and similarities between Tourette disorder and obsessive-compulsive disorder. Rev. Neurol., 2018, 174, 199-202.
[21]
Coryell, W. Obsessive-compulsive disorder and primary unipolar depression. Comparisons of background, family history, course, and mortality. J. Nerv. Ment. Dis., 1981, 169(4), 220-224.
[22]
Goodwin, D.W.; Guze, S.B.; Robins, E. Follow-up studies in obsessional neurosis. Arch. Gen. Psychiatry, 1969, 20(2), 182-187.
[23]
Kringlen, E. Obsessional neurotics: A long-term follow-up. Br. J. Psychiatry, 1965, 111, 709-722.
[24]
Harris, E.C.; Barraclough, B. Suicide as an outcome for mental disorders. A meta-analysis. Br. J. Psychiatry, 1997, 170, 205-228.
[25]
Mavissakalian, M.R.; Jones, B.; Olson, S. Absence of placebo response in obsessive-compulsive disorder. J. Nerv. Ment. Dis., 1990, 178, 268-270.
[26]
Walsh, B.T.; Seidman, S.N.; Sysko, R.; Gould, M. Placebo response in studies of major depression: Variable, substantial, and growing. JAMA, 2002, 287, 1840-1847.
[27]
Sysko, R.; Walsh, B.T. A systematic review of placebo response in studies of bipolar mania. J. Clin. Psychiatry, 2007, 68, 1213-1217.
[28]
Ackerman, D.L.; Greenland, S. Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder. J. Clin. Psychopharmacol., 2002, 22, 309-317.
[29]
Del Casale, A.; Kotzalidis, G.D.; Rapinesi, C.; Serata, D.; Ambrosi, E.; Simonetti, A.; Pompili, M.; Ferracuti, S.; Tatarelli, R.; Girardi, P. Functional neuroimaging in obsessive-compulsive disorder. Neuropsychobiology, 2011, 64(2), 61-85.
[30]
Del Casale, A.; Rapinesi, C.; Kotzalidis, G.D.; De Rossi, P.; Curto, M.; Janiri, D.; Criscuolo, S.; Alessi, M.C.; Ferri, V.R. De, Giorgi, R.; Sani, G.; Ferracuti, S.; Girardi, P.; Brugnoli, R. Executive functions in obsessive-compulsive disorder: An activation likelihood estimate meta-analysis of fMRI studies. World J. Biol. Psychiatry, 2016, 17(5), 378-393.
[31]
Bruin, W.; Denys, D.; van Wingen, G. Diagnostic neuroimaging markers of obsessive-compulsive disorder: Initial evidence from structural and functional MRI studies. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2019, 91, 49-59.
[32]
Marques, L.; Weingarden, H.M.; Leblanc, N.J.; Wilhelm, S. Treatment utilization and barriers to treatment engagement among people with body dysmorphic symptoms. J. Psychosom. Res., 2011, 70, 286-293.
[33]
Ishak, W.W.; Bolton, M.A.; Bensoussan, J-C.; Dous, G.V.; Nguyen, T.T.; Powell-Hicks, A.L.; Gardner, J.E.; Ponton, K.M. Quality of life in body dysmorphic disorder. CNS Spectr., 2012, 17, 167-175.
[34]
Weingarden, H.; Renshaw, K.D.; Wilhelm, S.; Tangney, J.P.; DiMauro, J. Anxiety and shame as risk factors for depression, suicidality, and functional impairment in body dysmorphic disorder and obsessive compulsive disorder. J. Nerv. Ment. Dis., 2016, 204, 832-839.
[35]
Grant, J.E.; Chamberlain, S.R. Trichotillomania. Am. J. Psychiatry, 2016, 173(9), 868-874.
[36]
Grant, J.E.; Odlaug, B.L.; Chamberlain, S.R.; Keuthen, N.J.; Lochner, C.; Stein, D.J. Skin picking disorder. Am. J. Psychiatry, 2012, 169(11), 1143-1149.
[37]
Williams, W.A.; Potenza, M.N. The neurobiology of impulse control disorders. Rev. Bras. Psiquiatr., 2008, 30(Suppl. 1), S24-S30.
[38]
Grant, J.E.; Odlaug, B.L.; Chamberlain, S.R. Neural and psychological underpinnings of gambling disorder: A review. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2016, 65, 188-193.
[39]
Isobe, M.; Redden, S.A.; Keuthen, N.J.; Stein, D.J.; Lochner, C.; Grant, J.E.; Chamberlain, S.R. Striatal abnormalities in trichotillomania: A multi-site MRI analysis. Neuroimage Clin., 2018, 17, 893-898.
[40]
Bais, M.; Figee, M.; Denys, D. Neuromodulation in obsessive-compulsive disorder. Psychiatr. Clin. North Am., 2014, 37, 393-413.
[41]
Saba, G.; Moukheiber, A.; Pelissolo, A. Transcranial cortical stimulation in the treatment of obsessivecompulsive disorders: efficacy studies. Curr. Psychiatry Rep., 2015, 17, 36.
[42]
Giffin, M.; Figee, M.; Denys, D. Deep brain stimulation for the treatment of obsessive–compulsive disorder. In: Hamani C, Holtzheimer P, Lozano AM, Mayberg H (Eds.). Neuromodulation in Psychiatry; . Chichester, West Sussex, UK: John Wiley & Sons, Ltd, 2016, pp. 295-307.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 17
ISSUE: 8
Year: 2019
Page: [668 - 671]
Pages: 4
DOI: 10.2174/1570159X1708190709144820

Article Metrics

PDF: 13
HTML: 2